Skip to main content
OpenTrials

Clinical trial condition

Blood Protein Disorders

Explore clinical trials studying Blood Protein Disorders. Study availability and eligibility vary by location and protocol.

3,039 public trials 566 recruiting studies
Refine in advanced search Browse all conditions

Blood Protein Disorders trial results

Completed

IV Busulfan Plus Bortezomib Conditioning Regimen for Second Autologous Stem Cell Transplant in Multiple Myeloma Patients

NCT01009840

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Arizona Cancer Center Tucson, Arizona, United States
  • Blood and Marrow Transplant Group of Georgia Atlanta, Georgia, United States
  • Loyola University Medical Center Maywood, Illinois, United States
  • Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States
View all 13 locations
View Trial Details
Completed

COM902 (A TIGIT Inhibitor) in Subjects With Advanced Malignancies

NCT04354246

Conditions
Adnexal Diseases, Advanced Cancer, Blood Protein Disorders, +53 more
Locations
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Massachusetts General Hospital. Boston, Massachusetts, United States
  • START Midwest. Grand Rapids, Michigan, United States
  • The Ohio State University Comprehensive Cancer Center. Columbus, Ohio, United States
View Trial Details
Completed

Study to Evaluate Safety Tolerability & Efficacy of Kyprolis (Carfilzomib) in Relapsed or Refractory Multiple Myeloma

NCT03934684

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Yashoda Hospital Hyderabad, Andhra Pradesh, India
  • Apollo Hospital Hyderabad, Andhra Pradesh, India
  • M S Ramaiah Memorial Hospital Bangalore, Karnataka, India
  • K L E S Dr Prabhakar Kore Hospital and Medical Research Centre Belagavi, Karnataka, India
View all 17 locations
View Trial Details
Completed

Clinical Assessment of Pharmacokinetics, Efficacy, and Safety of 10% IVIg in PID Patients

NCT03961009

Conditions
Agammaglobulinemia, Blood Protein Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +9 more
Locations
  • Allergy Associates of the Palm Beaches North Palm Beach, Florida, United States
  • Rush University Medical Center Chicago, Illinois, United States
  • Dr. Henry J. Kanarek - Allergy, Asthma & Immunology Overland Park, Kansas, United States
  • Midwest Immunology Clinic and Infusion Center Plymouth, Minnesota, United States
View Trial Details
Completed

Study to Investigate Alternative Dosing Regimens of Belantamab Mafodotin in Participants With Relapsed or Refractory Multiple Myeloma

NCT05064358

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • GSK Investigational Site West Palm Beach, Florida, United States
  • GSK Investigational Site Kansas City, Missouri, United States
  • GSK Investigational Site New York, United States
  • GSK Investigational Site Chattanooga, Tennessee, United States
View all 77 locations
View Trial Details

Related conditions